Lizamma Antony

1.2k total citations
20 papers, 901 citations indexed

About

Lizamma Antony is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lizamma Antony has authored 20 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Lizamma Antony's work include Prostate Cancer Treatment and Research (13 papers), Ubiquitin and proteasome pathways (4 papers) and Hormonal and reproductive studies (3 papers). Lizamma Antony is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Ubiquitin and proteasome pathways (4 papers) and Hormonal and reproductive studies (3 papers). Lizamma Antony collaborates with scholars based in United States, Sweden and India. Lizamma Antony's co-authors include John T. Isaacs, Susan L. Dalrymple, Ivan V. Litvinov, Donald J. Vander Griend, Angelo M. De Marzo, Yi Xu, Samuel R. Denmeade, Jason M. D’Antonio, Vivien C. Yee and Jun Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and PLoS ONE.

In The Last Decade

Lizamma Antony

19 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizamma Antony United States 15 519 441 230 122 122 20 901
Katia Coulonval Belgium 20 609 1.2× 220 0.5× 456 2.0× 262 2.1× 136 1.1× 28 1.1k
Bekir Cinar United States 22 686 1.3× 424 1.0× 223 1.0× 134 1.1× 255 2.1× 29 1.3k
Julia Hoefer Austria 14 416 0.8× 333 0.8× 268 1.2× 119 1.0× 272 2.2× 18 828
Michal Grzmil Switzerland 20 834 1.6× 166 0.4× 144 0.6× 44 0.4× 187 1.5× 32 1.2k
Moshit Lindzen Israel 20 524 1.0× 196 0.4× 393 1.7× 38 0.3× 73 0.6× 32 889
Stefan Preković Netherlands 16 678 1.3× 492 1.1× 348 1.5× 161 1.3× 276 2.3× 48 1.3k
Peter Hammarsten Sweden 19 482 0.9× 433 1.0× 261 1.1× 86 0.7× 273 2.2× 27 1.2k
Eneda Toska United States 17 855 1.6× 227 0.5× 263 1.1× 26 0.2× 210 1.7× 36 1.1k
Joaquim Calbó Spain 17 540 1.0× 87 0.2× 463 2.0× 72 0.6× 127 1.0× 23 1.1k
C Lee United States 11 429 0.8× 315 0.7× 149 0.6× 123 1.0× 131 1.1× 15 799

Countries citing papers authored by Lizamma Antony

Since Specialization
Citations

This map shows the geographic impact of Lizamma Antony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizamma Antony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizamma Antony more than expected).

Fields of papers citing papers by Lizamma Antony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizamma Antony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizamma Antony. The network helps show where Lizamma Antony may publish in the future.

Co-authorship network of co-authors of Lizamma Antony

This figure shows the co-authorship network connecting the top 25 collaborators of Lizamma Antony. A scholar is included among the top collaborators of Lizamma Antony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizamma Antony. Lizamma Antony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Isaacs, John T., Susan L. Dalrymple, Lizamma Antony, et al.. (2023). Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer. The Prostate. 83(15). 1470–1493. 3 indexed citations
3.
Antony, Lizamma, Oren Levy, Nitin Joshi, et al.. (2020). Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer. Molecular Cancer Therapeutics. 19(11). 2353–2362. 3 indexed citations
4.
Brennen, W. Nathaniel, Daniel L.J. Thorek, Timothy Krueger, et al.. (2020). Overcoming Stromal Barriers to Immuno-Oncological Responses via Fibroblast Activation Protein-Targeted Therapy. Immunotherapy. 13(2). 155–175. 21 indexed citations
5.
Brennen, W. Nathaniel, Baohui Zhang, İbrahim Kulaç, et al.. (2017). Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. Oncotarget. 8(29). 46710–46727. 25 indexed citations
6.
Graham, Mindy K., et al.. (2016). Low p16INK4aExpression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone. The Prostate. 77(4). 374–384. 13 indexed citations
7.
Antony, Lizamma, et al.. (2016). Abstract 2076: Albumin-linked proaerolysin based molecular grenades: A systemic therapeutic for disseminated castration resistant prostate cancer. Cancer Research. 76(14_Supplement). 2076–2076. 3 indexed citations
8.
9.
Isaacs, John T., Lizamma Antony, Susan L. Dalrymple, et al.. (2012). Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment. Cancer Research. 73(4). 1386–1399. 89 indexed citations
10.
Isaacs, John T., Jason M. D’Antonio, Shuangling Chen, et al.. (2012). Adaptive auto‐regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer. The Prostate. 72(14). 1491–1505. 79 indexed citations
11.
12.
Griend, Donald J. Vander, Jason M. D’Antonio, Bora Gürel, et al.. (2009). Cell‐autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. The Prostate. 70(1). 90–99. 34 indexed citations
13.
Lee, Seung‐Joo, Lizamma Antony, Rune Hartmann, et al.. (2009). Conformational diversity in prion protein variants influences intermolecular β‐sheet formation. The EMBO Journal. 29(1). 251–262. 88 indexed citations
14.
Griend, Donald J. Vander, Lizamma Antony, Susan L. Dalrymple, et al.. (2009). Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells. Molecular Cancer Therapeutics. 8(5). 1340–1349. 34 indexed citations
15.
Litvinov, Ivan V., Donald J. Vander Griend, Yi Xu, et al.. (2006). Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells. Cancer Research. 66(17). 8598–8607. 115 indexed citations
16.
Litvinov, Ivan V., Lizamma Antony, Susan L. Dalrymple, et al.. (2006). PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. The Prostate. 66(12). 1329–1338. 85 indexed citations
17.
Litvinov, Ivan V., Donald J. Vander Griend, Lizamma Antony, et al.. (2006). Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proceedings of the National Academy of Sciences. 103(41). 15085–15090. 101 indexed citations
18.
Dalrymple, Susan L., Lizamma Antony, Yi Xu, et al.. (2005). Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells. Cancer Research. 65(20). 9269–9279. 63 indexed citations
19.
Hall, Pamela R., Run Zheng, Lizamma Antony, et al.. (2004). Transcarboxylase 5S structures: assembly and catalytic mechanism of a multienzyme complex subunit. The EMBO Journal. 23(18). 3621–3631. 39 indexed citations
20.
Litvinov, Ivan V., Lizamma Antony, & John T. Isaacs. (2004). Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor. The Prostate. 61(4). 299–304. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Coulonval Breakdown of academic impact, for papers by Bekir Cinar Breakdown of academic impact, for papers by Julia Hoefer Breakdown of academic impact, for papers by Michal Grzmil Breakdown of academic impact, for papers by Moshit Lindzen Breakdown of academic impact, for papers by Stefan Preković Breakdown of academic impact, for papers by Peter Hammarsten Breakdown of academic impact, for papers by Eneda Toska Breakdown of academic impact, for papers by Joaquim Calbó Breakdown of academic impact, for papers by C Lee
Rankless by CCL
2026